More recently, Easton et al. [22] sequenced the coding region of BRIP1 in more than 13,000 population-based breast cancer cases and 8000 controls, and found no excess of truncating mutations in cases relative to controls (0.21 % vs 0.23 %, respectively). This evidence concerns the gene BRIP1 and breast cancer.